Inhibition of tumor growth and angiogenesis of tamoxifen‑resistant breast cancer cells by ruxolitinib, a selective JAK2 inhibitor
Keyword(s):
2020 ◽
Vol 84
◽
pp. 108437
◽
Keyword(s):
Keyword(s):
2008 ◽
Vol 112
(3)
◽
pp. 389-403
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):